selfotel has been researched along with Arterial Occlusive Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou-Gharbia, M; Baudy, RB; Bramlett, DR; Fletcher, H; Katz, AH; Kowal, DM; Moyer, JA; Tasse, RP; Yardley, JP; Zaleska, MM | 1 |
Haapalinna, A; Jolkkonen, J; Kauppinen, R; Koistinaho, J; Nieminen, L; Puurunen, K; Sivenius, J | 1 |
Choi, DW; Zivin, JA | 1 |
1 trial(s) available for selfotel and Arterial Occlusive Diseases
Article | Year |
---|---|
Stroke therapy.
Topics: Animals; Arterial Occlusive Diseases; Calcium; Cell Survival; Cerebral Arterial Diseases; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Tissue Plasminogen Activator; Tomography, Emission-Computed | 1991 |
2 other study(ies) available for selfotel and Arterial Occlusive Diseases
Article | Year |
---|---|
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
Topics: Animals; Arterial Occlusive Diseases; Benzimidazoles; Binding, Competitive; Brain; Carotid Artery Diseases; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Mice; Models, Molecular; Neuroprotective Agents; Organophosphonates; Propionates; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; Stereoisomerism | 2001 |
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
Topics: Adrenergic alpha-Agonists; Animals; Arterial Occlusive Diseases; Body Weight; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Excitatory Amino Acid Antagonists; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar | 1999 |